EP0664813A4 - Polypeptide inhibiteur de cetp, anticorps contre ce polypeptide synthetique et traitements prophylactique et therapeutique de l'atherosclerose. - Google Patents

Polypeptide inhibiteur de cetp, anticorps contre ce polypeptide synthetique et traitements prophylactique et therapeutique de l'atherosclerose.

Info

Publication number
EP0664813A4
EP0664813A4 EP94925711A EP94925711A EP0664813A4 EP 0664813 A4 EP0664813 A4 EP 0664813A4 EP 94925711 A EP94925711 A EP 94925711A EP 94925711 A EP94925711 A EP 94925711A EP 0664813 A4 EP0664813 A4 EP 0664813A4
Authority
EP
European Patent Office
Prior art keywords
polypeptide
prophylactic
antibodies against
cetp inhibitor
therapeutic anti
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94925711A
Other languages
German (de)
English (en)
Other versions
EP0664813A1 (fr
Inventor
Rampratap S Kushwaha
Henry C Mcgill Jr
Patrick Kanda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Texas Biomedical Research Institute
Original Assignee
Texas Biomedical Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Texas Biomedical Research Institute filed Critical Texas Biomedical Research Institute
Publication of EP0664813A1 publication Critical patent/EP0664813A1/fr
Publication of EP0664813A4 publication Critical patent/EP0664813A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
EP94925711A 1993-08-04 1994-08-02 Polypeptide inhibiteur de cetp, anticorps contre ce polypeptide synthetique et traitements prophylactique et therapeutique de l'atherosclerose. Withdrawn EP0664813A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10216093A 1993-08-04 1993-08-04
US102160 1993-08-04
PCT/US1994/008624 WO1995004755A1 (fr) 1993-08-04 1994-08-02 Polypeptide inhibiteur de cetp, anticorps contre ce polypeptide synthetique et traitements prophylactique et therapeutique de l'atherosclerose

Publications (2)

Publication Number Publication Date
EP0664813A1 EP0664813A1 (fr) 1995-08-02
EP0664813A4 true EP0664813A4 (fr) 1998-05-27

Family

ID=22288420

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94925711A Withdrawn EP0664813A4 (fr) 1993-08-04 1994-08-02 Polypeptide inhibiteur de cetp, anticorps contre ce polypeptide synthetique et traitements prophylactique et therapeutique de l'atherosclerose.

Country Status (6)

Country Link
EP (1) EP0664813A4 (fr)
JP (1) JPH08502525A (fr)
KR (1) KR950703580A (fr)
AU (1) AU683295B2 (fr)
CA (1) CA2145767A1 (fr)
WO (1) WO1995004755A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0831881T3 (da) 1995-06-06 2003-07-07 Avant Immunotherapeutics Inc CETP til forøgelse af HDL-cholesterolniveau
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011782A1 (fr) * 1991-12-19 1993-06-24 Southwest Foundation For Biomedical Research Polypeptide inhibant la proteine de transfert aux esters de cholesteryl, anticorps contre le polypeptide synthetique et traitements prophylactiques et therapeutiques anti-atherosclerose

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904481A (en) * 1985-04-17 1990-02-27 The Board Of Trustess Of Leland Stanford University Method of conferring immuno-tolerance to a specific antigen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993011782A1 (fr) * 1991-12-19 1993-06-24 Southwest Foundation For Biomedical Research Polypeptide inhibant la proteine de transfert aux esters de cholesteryl, anticorps contre le polypeptide synthetique et traitements prophylactiques et therapeutiques anti-atherosclerose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9504755A1 *

Also Published As

Publication number Publication date
JPH08502525A (ja) 1996-03-19
WO1995004755A1 (fr) 1995-02-16
KR950703580A (ko) 1995-09-20
CA2145767A1 (fr) 1995-02-16
AU7552694A (en) 1995-02-28
AU683295B2 (en) 1997-11-06
EP0664813A1 (fr) 1995-08-02

Similar Documents

Publication Publication Date Title
EP0618803A4 (fr) Polypeptide inhibant la proteine de transfert aux esters de cholesteryl, anticorps contre le polypeptide synthetique et traitements prophylactiques et therapeutiques anti-atherosclerose.
ZA949341B (en) Humanized antibodies and uses thereof
HUP9802217A3 (en) Recombinant mva virus, and the use thereof
EP0632099A3 (fr) Organopolysiloxan et méthode pour le préparer.
EP0650844A3 (fr) Imprimantes de type navette et méthodes pour sa mise en oeuvre.
EP0678723A4 (fr) Arbalete de nizov.
EP0663554A3 (fr) Bague avec patins de glissement et méthode pour sa fabrication.
EP0608546A3 (en) Glia activating factor (gaf), antibodies against it and their uses.
EP0625349A3 (fr) Applicateur à surface modifiée et leur procédés.
ZA931530B (en) Valve.
EP0662290A3 (fr) Fermoir.
EP0611859A3 (fr) Ferrure de sécurité.
EP0738144A4 (fr) Hexanamides de phenylmethyle et leur utilisation
EP0669396A4 (fr) Nouveau polypeptide et adn codant pour celui-ci.
EP0658768A3 (fr) Réduction d'interférence du fond dans le molybdate-colorant procédé pour déterminer des protéines.
EP0607961A3 (en) Polyester composition and process for producing the same.
EP0679658A4 (fr) Peptide a effet antagoniste de l'endotheline.
EP0650522A4 (fr) Nouvelles cyclophilines, proteines s'associant a ces cyclophilines et leurs utilisations.
EP0626303A3 (fr) Aménagement de soupape.
EP0651178A3 (fr) Dispositif de jonction de courroie.
EP0664498A4 (fr) Procede de designation de region.
EP0661487A3 (fr) Soupape.
EP0601354A3 (en) Dicyanate prepolymers, use and preparation thereof.
EP0653162A4 (fr) Colletotrichum et son utilisation.
EP0657693A3 (fr) Brûleur à gaz.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19950331

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched
AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 19990305

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

RTI1 Title (correction)

Free format text: CETP INHIBITOR POLYPEPTID, PROPHYLACTIC AND THERAPEUTIC ANTI-ATHEROSCLEROSIS TREATMENTS

18W Application withdrawn

Withdrawal date: 20000527